BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 2134685)

  • 1. Monitoring carcinogen actions on DNA by 32P-postlabeling.
    Randerath K; Randerath E
    Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
    Randerath K; Randerath E
    J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous and endogenous DNA modifications as monitored by 32P-postlabeling: relationships to cancer and aging.
    Randerath K; Li D; Nath R; Randerath E
    Exp Gerontol; 1992; 27(5-6):533-49. PubMed ID: 1426086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative 32P-analysis of cigarette smoke-induced DNA damage in human tissues and mouse skin.
    Randerath E; Avitts TA; Reddy MV; Miller RH; Everson RB; Randerath K
    Cancer Res; 1986 Nov; 46(11):5869-77. PubMed ID: 3756927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of induced sputum for molecular dosimetry of exposure to inhalatory carcinogens: 32P-postlabeling of lipophilic DNA adducts in smokers and nonsmokers.
    Besaratinia A; Maas LM; Van Breda SG; Curfs DM; Kleinjans JC; Wouters EF; Van Schooten FJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):367-72. PubMed ID: 10794480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity.
    Talaska G; Schamer M; Skipper P; Tannenbaum S; Caporaso N; Unruh L; Kadlubar FF; Bartsch H; Malaveille C; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):61-6. PubMed ID: 1845172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.
    Gupta RC
    Cancer Res; 1985 Nov; 45(11 Pt 2):5656-62. PubMed ID: 4053037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells from coke oven workers: correlation with job categories.
    Ovrebø S; Haugen A; Phillips DH; Hewer A
    Cancer Res; 1992 Mar; 52(6):1510-4. PubMed ID: 1540959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical (postlabelling) methods for analysis of carcinogen-DNA adducts.
    Randerath K; Randerath E; Agrawal HP; Reddy MV
    IARC Sci Publ; 1984; (59):217-31. PubMed ID: 6443609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
    Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
    Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene.
    Lu LJ; Disher RM; Reddy MV; Randerath K
    Cancer Res; 1986 Jun; 46(6):3046-54. PubMed ID: 3698023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring human exposure to carcinogens by ultrasensitive postlabelling assays: application to unidentified genotoxicants.
    Randerath K; Miller RH; Mittal D; Randerath E
    IARC Sci Publ; 1988; (89):361-7. PubMed ID: 3198221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology.
    Li D; Wang M; Dhingra K; Hittelman WN
    Cancer Res; 1996 Jan; 56(2):287-93. PubMed ID: 8542582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
    Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH
    Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 32P-postlabeling assay for DNA adducts.
    Phillips DH; Arlt VM
    Nat Protoc; 2007; 2(11):2772-81. PubMed ID: 18007613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of DNA adducts in human oral tissue: correlation of adduct levels with tobacco smoking and differential enhancement of adducts using the butanol extraction and nuclease P1 versions of 32P postlabeling.
    Jones NJ; McGregor AD; Waters R
    Cancer Res; 1993 Apr; 53(7):1522-8. PubMed ID: 8453617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatic DNA adducts in white blood cells of foundry workers.
    Hemminki K; Perera FP; Phillips DH; Randerath K; Reddy MV; Santella RM
    IARC Sci Publ; 1988; (89):190-5. PubMed ID: 3143668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for testing compounds for DNA adduct formation.
    Reddy MV
    Regul Toxicol Pharmacol; 2000 Dec; 32(3):256-63. PubMed ID: 11162719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences of DNA isolation and RNA contamination on carcinogen-DNA adduct analysis by 32P-postlabeling.
    Godschalk RW; Maas LM; Kleinjans JC; Van Schooten FJ
    Environ Mol Mutagen; 1998; 32(4):344-50. PubMed ID: 9882009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.